Canada HIV Market Analysis


  • Type: Common Disease Area
  • Published : April 2021
  • Region: North America
  • Country: Canada
  • Report ID : 3161

  • Format: PPT, PDF

Canada HIV Drugs Market: Segmented By Product (Consumables, Instruments, and Software & Services), By Drug Class (Nucleoside Reverse Transcriptase Inhibitors, Multi-Class Combination Products, Protease Inhibitors, HIV Integrase Strand Transfer Inhibitors, Non-Nucleoside Reverse Transcriptase Inhibitors, and Others), By Test Type (Antibody Tests, Viral Load Tests, CD4 Tests, and Others), By End- User (Hospital, Blood Banks, Home Care Settings, Diagnostic Laboratories, Other End Users) – Growth, Trends & Forecast (2019 – 2028)

SKU: 3161 Categories: ,

Canada’s HIV Drugs Market size stood at USD 789.8 million in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of XX% during the forecast period.

The Public Health Agency of Canada’s (PHAC) 2018 HIV Surveillance Report revealed that the number of new HIV rates in Canada is on the rise for the fourth consecutive year. They have increased by 25.3% since 2014. Currently, more than 68,000 Canadians are living with HIV, with 14% unaware that they have been infected. The diagnosis rate for males in 2019 was higher than that for females (7.9 versus 3.4 per 100,000 population, respectively).The Canadian AIDS Society (CAS) claimed that the rise in HIV rates is primarily due to funding cuts to local HIV organizations receiving assistance from PHAC’s HIV and Hepatitis C Community Action Fund in 2016. Nearly 40% of community-based HIV organizations lost their funding for not aligning with the Canadian government’s new focus on prevention.

Market Drivers

The major factors that boost the HIV drug market growth include an increase in the prevalence of HIV, increasing number of blood transfusions and blood donations, benefits offered by Point-of-care instruments & kits, increasing government initiatives, rise in treatment & diagnosis rate. A vital factor driving the HIV market growth is the government and various NGOs to provide at-risk individuals with greater accessibility to disease testing and treatment for infected persons. As part of a global movement to eliminate sexually transmitted and blood-borne infections (STBBI) as a health concern by 2028, the Public Health Agency of Canada (PHAC) published reducing the health impact of sexually transmitted and blood-borne infections in Canada by 2028. A pan Canadian STBBI framework for action. This framework and its associated government of Canada action plan demonstrate a commitment to reducing the burden of STBBI in Canada through the core pillars of prevention, testing, initiation of care and treatment, and ongoing maintenance and support.

1. Canada HIV Drugs Market Overview…………………………………………..
A. Market Size
2. Market Growth Drivers………………………………………………………………….
A. Increase in Prevalence of HIV
B. Increasing Number of Blood Transfusions and Blood Donations
C. Government Initiatives
3. Types of HIV Test…………………………………………………………………………..
A. Rapid HIV Test
B. Standard Testing
C. Early Detection
D. HIV Antibody Test
E. HIV Antigen Test
4. HIV Drugs Market Segmentation ………………………………………………
A. By Product
I. Consumables
I. Instruments
II. Software & Services
B. By Drug Class
I. Nucleoside Reverse Transcriptase Inhibitors
II. Multi-Class Combination Products
III. Protease Inhibitors
IV. HIV Integrase Strand Transfer Inhibitors
V. Non-Nucleoside Reverse Transcriptase Inhibitors
VI. Others
C. By Test Type
I. Antibody Tests
II. Viral Load Tests
III. CD4 Tests
IV. Others
D. By End-User
I. Hospital
II. Diagnostic Laboratories
III. Other End Users
5. HIV Major Drugs Market Share……………………………………..
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape…………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………………………………………………………………..
A. Merck & Co., Company overview, Product & Services, Strategies & Financials
B. Gilead Sciences Company overview, Product & Services, Strategies & Financials
C. Johnson & Johnson Company, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape…………………………………….
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth………………………………………………………….
A. New Trends and Development of HIV drug market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Product:

The market is segmented into consumables (assay, kits, reagents, and other consumables), instruments, and software and services based on the product. The consumables segment has accounted for the largest share of the market. The frequent and repetitive purchase of consumables by laboratories and hospitals, the growing prevalence of HIV/AIDS, and increasing initiatives from governments to fight HIV/AIDS are significant factors driving the consumables market.

By Drug Class:

Canadian HIV drugs market is classified into Nucleoside Reverse Transcriptase Inhibitors, Multi-Class Combination Products, Protease Inhibitors, HIV Integrase Strand Transfer Inhibitors, Non-Nucleoside Reverse Transcriptase Inhibitors, Entry Inhibitors – CCR5 Co-Receptor Antagonist, and Others Based on the drug class.

By Test Type:

This market is segmented into Antibody Tests, Viral Load Tests, CD4 Tests, and others based on the test type. The Antibody Test segment that detects HIV antibodies in your blood or saliva accounts for the most significant part of the Market.

By End-User:

Based on end-user, the HIV drugs market is segmented into diagnostic laboratories, hospitals, other end users. The diagnostic laboratories segment is expected to account for the largest share of the HIV diagnosis market in coming years. Increasing awareness about HIV/AIDS and advancements in Point of Care instruments and consumables are significant drivers for this end-user segment.

Top 5 Major Players

As HIV treatments are entering into a new era, Canada has become the first nation in the world to approve ViiV Healthcare’s monthly long-acting injectable antiretroviral (ARV) regimen Cabenuva (cabotegravir/rilpivirine), the first complete regimen for treating the virus that does not require daily pills.

Major Players are Merck & Co., Inc. F. Hoffmann-La Roche Ltd., Gilead Sciences, Inc., Cipla Inc., and Johnson & Johnson Services, Inc., etc.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements